BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
i3 Verticals
IIIV
$325M
| $34.5M | ﹤0.01% |
1,424,356
+50,311
| +4% | +$1.45M |
|
2902
PureCycle Technologies
PCT
$1.41B
| $34.4M | ﹤0.01% |
2,590,775
-117
| -0% | -$1.76K |
|
|
SKYT
2903
DELISTED
SkyWater Technology
SKYT
| $34.4M | ﹤0.01% |
1,263,775
+39,175
| +3% | +$1.02M |
|
|
ZYXI
2904
DELISTED
Zynex
ZYXI
| $34.3M | ﹤0.01% |
3,311,875
+30,285
| +0.9% | +$389K |
|
|
GRTS
2905
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $34.3M | ﹤0.01% |
3,174,318
+319,450
| +11% | +$2.91M |
|
|
TRUE
2906
DELISTED
TrueCar
TRUE
| $34.2M | ﹤0.01% |
8,228,462
-78,198
| -0.9% | -$363K |
|
|
MRNS
2907
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $34.1M | ﹤0.01% |
2,997,203
-17,825
| -0.6% | -$245K |
|
|
QUOT
2908
DELISTED
Quotient Technology Inc
QUOT
| $34M | ﹤0.01% |
5,838,748
+134,892
| +2% | +$1.13M |
|
2909
TotalEnergies
TTE
$193B
| $33.9M | ﹤0.01% |
707,692
+26,390
| +4% | +$1.17M |
|
2910
Hovnanian Enterprises
HOV
$799M
| $33.9M | ﹤0.01% |
351,751
+7,751
| +2% | +$774K |
|
2911
Tidewater
TDW
$4.55B
| $33.9M | ﹤0.01% |
2,808,222
-41,329
| -1% | -$470K |
|
2912
SmartRent
SMRT
$276M
| $33.8M | ﹤0.01% |
2,597,750
+5,334
| +0.2% | +$66K |
|
|
HCIC
2913
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
| $33.7M | ﹤0.01% |
3,415,500
| – | – |
|
2914
VSE Corp
VSEC
$6.48B
| $33.6M | ﹤0.01% |
698,141
-6,308
| -0.9% | -$307K |
|
|
HUYA
2915
Huya Inc
HUYA
$538M
| $33.6M | ﹤0.01% |
4,030,741
+234,719
| +6% | +$2.71M |
|
2916
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $33.5M | ﹤0.01% |
669,463
+392,821
| +142% | +$20.3M |
|
2917
Frontier Group Holdings
ULCC
$1.57B
| $33.5M | ﹤0.01% |
2,118,752
+67,551
| +3% | +$1.04M |
|
2918
Tenaya Therapeutics
TNYA
$164M
| $33.4M | ﹤0.01% |
+1,619,719
| New | +$34.8M |
|
|
BRY
2919
DELISTED
Berry Corp
BRY
| $33.4M | ﹤0.01% |
4,637,424
-41,850
| -0.9% | -$247K |
|
2920
Aemetis
AMTX
$126M
| $33.4M | ﹤0.01% |
1,827,584
+180,034
| +11% | +$1.99M |
|
2921
Altimmune
ALT
$560M
| $33.3M | ﹤0.01% |
2,941,790
+384,548
| +15% | +$4.68M |
|
2922
Outdoor Holding Co
POWW
$255M
| $33.2M | ﹤0.01% |
5,400,380
+905,379
| +20% | +$6.52M |
|
|
UHG
2923
DELISTED
United Homes Group
UHG
| $33.2M | ﹤0.01% |
3,415,500
| – | – |
|
2924
Spero Therapeutics
SPRO
$71.8M
| $33.2M | ﹤0.01% |
1,802,528
+23,706
| +1% | +$380K |
|
2925
Global Industrial
GIC
$1.49B
| $33.1M | ﹤0.01% |
873,797
-14,696
| -2% | -$552K |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.